Literature DB >> 8284019

Uveitis and pseudojaundice during a regimen of clarithromycin, rifabutin, and ethambutol. MAC Study Group of the Canadian HIV Trials Network.

S D Shafran, J Deschênes, M Miller, P Phillips, E Toma.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 8284019     DOI： 10.1056/NEJM199402103300616

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  20 in total

Review 1.  Drug-Drug interactions of clinical significance in the treatment of patients with Mycobacterium avium complex disease.

Authors:  J I Kuper; M D'Aprile
Journal:  Clin Pharmacokinet       Date:  2000-09       Impact factor: 6.447

2.  Re: The new macrolide antibiotics: Use them carefully.

Authors:  M Greenwald
Journal:  Paediatr Child Health       Date:  1998-07       Impact factor: 2.253

Review 3.  Risk-benefit assessment of therapies for Mycobacterium avium complex infections.

Authors:  D E Griffith
Journal:  Drug Saf       Date:  1999-08       Impact factor: 5.606

4.  Uveitis associated with rifabutin and macrolide therapy for Mycobacterium avium intracellulare infection in AIDS patients.

Authors:  P Kelleher; M Helbert; J Sweeney; J Anderson; J Parkin; A Pinching
Journal:  Genitourin Med       Date:  1996-12

5.  Tolerance and pharmacokinetic interactions of rifabutin and clarithromycin in human immunodeficiency virus-infected volunteers.

Authors:  R Hafner; J Bethel; M Power; B Landry; M Banach; L Mole; H C Standiford; S Follansbee; P Kumar; R Raasch; D Cohn; D Mushatt; G Drusano
Journal:  Antimicrob Agents Chemother       Date:  1998-03       Impact factor: 5.191

Review 6.  Drug-induced uveitis. Incidence, prevention and treatment.

Authors:  F W Fraunfelder; J T Rosenbaum
Journal:  Drug Saf       Date:  1997-09       Impact factor: 5.606

7.  Metabolism of rifabutin and its 25-desacetyl metabolite, LM565, by human liver microsomes and recombinant human cytochrome P-450 3A4: relevance to clinical interaction with fluconazole.

Authors:  C B Trapnell; C Jamis-Dow; R W Klecker; J M Collins
Journal:  Antimicrob Agents Chemother       Date:  1997-05       Impact factor: 5.191

8.  Anterior uveitis associated with rifabutin medication in AIDS patients.

Authors:  K Becker; M Schimkat; H Jablonowski; D Häussinger
Journal:  Infection       Date:  1996 Jan-Feb       Impact factor: 3.553

Review 9.  Clinically significant drug interactions with antituberculosis agents.

Authors:  J M Grange; P A Winstanley; P D Davies
Journal:  Drug Saf       Date:  1994-10       Impact factor: 5.606

Review 10.  Adverse effects of drugs used in the management of opportunistic infections associated with HIV infection.

Authors:  B S Peters; E Carlin; R J Weston; S J Loveless; J Sweeney; J Weber; J Main
Journal:  Drug Saf       Date:  1994-06       Impact factor: 5.606
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.